Biocon Q4 profit drops 57%, but biosimilars business shines
Published on: May 8, 2026, 11:12 a.m. | Source: The Hindu Business Line
Biocon's Q4 profit drops 57% due to exceptional items, but biosimilars and generics segments show strong growth.
Trusted Mumbai Loan Experts
Business, Home, Mortgage & Personal Loans. Since 2001
Planning a trip to Singapore?
Let's make it a seamless journey, bhai — full of fun, food, and unforgettable vibes! 🌟✈️
Contact Now